Ecolab Inc v. SC Johnson Professional Group Limited

Court of Appeals for the Third Circuit·Decided July 20, 2026·No. 25-2033·Unpublished

Opinion

NOT PRECEDENTIAL

UNITED STATES COURT OF APPEALS FOR THE THIRD CIRCUIT

No. 25-2033

ECOLAB INC.;

ECOLAB USA INC.,

Appellants

v.

SC JOHNSON PROFESSIONAL GROUP LIMITED, formerly known as DEB Group Limited;

DEB IP LIMITED

On Appeal from the United States District Court for the District of Delaware (D.C. Civil No. 1:23-cv-00170)

District Judge: Honorable Richard G. Andrews

Submitted Pursuant to Third Circuit L.A.R. 34.1(a)

on March 24, 2026

Before: HARDIMAN, SCIRICA, and AMBRO, Circuit Judges.

(Filed: July 20, 2026)

OPINION*

*

This disposition is not an opinion of the full Court and pursuant to I.O.P. 5.7 does not constitute binding precedent.

SCIRICA, Circuit Judge This case involves an interpretive dispute over a contract governing one company’s right to enforce another company’s patents. Deb Group, now known as SC Johnson Professional Group, granted Ecolab Inc. a non-exclusive license to make and sell patented hand sanitizer and skin-care products. Deb also granted Ecolab the right to bring suits against certain infringers of those same patents. However, Deb’s contract limited that right. Under its terms, Ecolab required an affirmative written communication from Deb granting permission to bring suit.

Ecolab contends it has the right to sue infringers of Deb’s patent under this contractual provision. Accordingly, this dispute turns on whether Ecolab can show Deb provided an affirmative written communication within the meaning of the contract. Ecolab presented several theories at the District Court, but now only directs our attention to a three-page 2022 letter from Deb. The District Court found this letter did not support Ecolab’s claim, in part because Deb twice explicitly states in the letter it was not an affirmative written communication. The Court dismissed the case and denied Ecolab’s motion to amend its complaint. We agree, and, since we find Ecolab’s alternative arguments unavailing, we will affirm.

I.1

The contract at issue is a patent license agreement resulting from two prior

lawsuits between the parties—an original agreement in 2013 and an amendment to that agreement in 2022. Collectively, these contracts granted Ecolab a non-exclusive, royalty- bearing license to make and sell certain hand and skin-sanitizing products patented by Deb.

These contracts also provided Ecolab with a conditional right to sue certain infringers of Deb’s patents. Those conditions arise from both the original 2013 language and the 2022 amendment language. Section 4.1 of the 2013 contract states:

[Deb] will take commercially reasonable steps to enforce its patents.

Should [Deb] elect, at its sole discretion, to not enforce their own patents against a third party infringer, [Ecolab] shall have the right to assert the patents against such third party infringers at its own expense.

App. 739. The 2022 amendment added a new provision, Section 4.1(a), which reads:

[Deb] shall have no affirmative obligation to [Ecolab] pursuant to this Section 4.1 to take any steps to enforce its patents. No action or inaction other than an affirmative written communication of an election by [Deb] to [Ecolab’s designated counsel] shall be deemed an election by Deb Group not to enforce its patents pursuant to this Section 4.1. For purposes of clarity, Ecolab acknowledges that . . . silence by [Deb], or any absence of communication from [Deb], shall not be considered an affirmative communication of any election.

App. 779.

Just ten days after this amendment went into effect, Ecolab sent a letter asserting Deb had provided an affirmative written communication permitting exercise of patent enforcement rights under Section 4.1—within the amended contract itself.2 Deb replied it

2 The theory Ecolab pressed at the time—though strikingly similar to its current theory—was dismissed by the District Court and raised only “in passing” in a footnote of

had “not made, and [was] not making in this letter, an election not to enforce the Deb Group Patents under Section 4.1 of the License Agreement.” App. 803. After another letter from Ecolab, this round of communication culminated in a three-page letter from Deb’s counsel, sent December 1, 2022, which is the subject of this case.3 Two passages from this December 1, 2022 letter are relevant to the resolution of this case.

The first, which is the language Ecolab directs our attention to, requires a bit of context. During prior exchanges between the companies, Ecolab had taken the position the two latest-expiring patents covered by the license agreement would be invalid after September 29, 2024 under a theory of obviousness-type double patenting,4 and accordingly contended it should not have to pay royalties after that date to Deb. Recognizing the obviousness-type double patenting issue, Deb stated it would not compel Ecolab to pay royalties on those patents after September 29, 2024—a commitment it later

Ecolab’s brief before us and is accordingly forfeited. DLJ Mortg. Cap., Inc. v. Stevens, 167 F.4th 632, 635 (3d Cir. 2026) (citations omitted).

3 The three pages at issue begin with a one-page letter from Deb dated December 1, 2022. That letter incorporated by reference a two-page letter from Deb’s outside counsel dated November 30, 2022. The parties and the District Court package the two letters together in their discussion, and we will do likewise.

4 Obviousness-type double patenting is a judicially created doctrine which prevents one party from obtaining multiple patents that cover obvious variants of the same invention. It functions, in part, so an inventor cannot artificially extend the life of one patent by getting a second patent covering an obvious variation of the same invention with a later expiration date. See Gilead Scis., Inc. v. Natco Pharma Ltd., 753 F.3d 1208, 1212–14 (Fed. Cir. 2014); see generally Daniel Kazhdan, Obviousness-Type Double Patenting: Why It Exists and When It Applies, 53 AKRON L. REV. 1017, 1023–28 (2019).

formalized in the 2022 settlement. See App. 750 (“Deb Group confirms it will not seek to enforce the [patents] in the United States, nor collect royalties thereon, for activities carried out in the United States by Deb Group licensees on and after September 30, 2024.”). However, after securing freedom from royalties and potential enforcement by Deb after September 29, 2024, Ecolab then asserted “at least some” claims from the two patents were not subject to obviousness-type double patenting, and as such should still be enforceable after September 29, 2024—by Ecolab. App. 809–10.

This brings us back to the December 1, 2022 letter. Deb, responding in the letter to Ecolab’s latest claim, pushed back on the idea “at least some” patents were immune from challenge by writing:

In any event, for the avoidance of doubt, [Deb] has independently analyzed all claims of the [patents] and has concluded that all are subject to an invalidity challenge due to obviousness type double patenting beyond September 29, 2024.

App. 818. Ecolab contends this language satisfied the written communication requirement under Section 4.1 of the amended 2022 contract. In other words, it believes this constituted Deb’s election not to enforce the patents, triggering Ecolab’s patent enforcement rights.

But there is a second item of note from Deb’s December 1, 2022 letter.

Immediately after the above quoted text, Deb wrote:

[Ecolab] do[es] not deny or otherwise substantively address the points made in [Deb’s first response] letter establishing that Ecolab has not triggered its rights under Section 4.1 of the License Agreement. . . . [Deb]

has not, and does not in this letter, take a position on its rights and obligations under Section 4.1. In other words, contrary to your assertion, there has been no breach as you have alleged.

Free access — add to your briefcase to read the full text and ask questions with AI

Ecolab Inc v. SC Johnson Professional Group Limited, (3d Cir. 2026).

Ecolab Inc v. SC Johnson Professional Group Limited (Ecolab Inc v. SC Johnson Professional Group Limited) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Mayer v. Belichick
605 F.3d 223 (Third Circuit, 2010)
Axis Reinsurance Co. v. Hlth Corp.
993 A.2d 1057 (Supreme Court of Delaware, 2010)
Nemec v. Shrader
991 A.2d 1120 (Supreme Court of Delaware, 2010)
Estate of Osborn Ex Rel. Osborn v. Kemp
991 A.2d 1153 (Supreme Court of Delaware, 2010)
Rhone-Poulenc Basic Chemicals Co. v. American Motorists Insurance Co.
616 A.2d 1192 (Supreme Court of Delaware, 1992)
Gilead Sciences, Inc. v. Natco Pharma Limited
753 F.3d 1208 (Federal Circuit, 2014)
Ina Collins v. Mary Kay Inc
874 F.3d 176 (Third Circuit, 2017)
Mission Product Holdings, Inc. v. Tempnology, LLC
587 U.S. 370 (Supreme Court, 2019)
Celgene Corporation v. Peter
931 F.3d 1342 (Federal Circuit, 2019)
Ram Construction Co. v. American States Insurance
749 F.2d 1049 (Third Circuit, 1984)
Don Ascolese v. Shoemaker Construction Co
55 F.4th 188 (Third Circuit, 2022)